Annual D&A
$262.80 K
+$4100.00+1.58%
December 31, 2023
Summary
- As of February 7, 2025, ALDX annual depreciation & amortization is $262.80 thousand, with the most recent change of +$4100.00 (+1.58%) on December 31, 2023.
- During the last 3 years, ALDX annual D&A has risen by +$206.60 thousand (+367.62%).
- ALDX annual D&A is now -0.53% below its all-time high of $264.20 thousand, reached on December 31, 2021.
Performance
ALDX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$63.00 K
+$1400.00+2.27%
September 30, 2024
Summary
- As of February 7, 2025, ALDX quarterly depreciation & amortization is $63.00 thousand, with the most recent change of +$1400.00 (+2.27%) on September 30, 2024.
- Over the past year, ALDX quarterly D&A has dropped by -$2000.00 (-3.08%).
- ALDX quarterly D&A is now -13.82% below its all-time high of $73.10 thousand, reached on September 30, 2020.
Performance
ALDX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$251.70 K
-$2000.00-0.79%
September 30, 2024
Summary
- As of February 7, 2025, ALDX TTM depreciation & amortization is $251.70 thousand, with the most recent change of -$2000.00 (-0.79%) on September 30, 2024.
- Over the past year, ALDX TTM D&A has dropped by -$11.20 thousand (-4.26%).
- ALDX TTM D&A is now -4.77% below its all-time high of $264.30 thousand, reached on December 31, 2021.
Performance
ALDX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
ALDX Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.6% | -3.1% | -4.3% |
| 3 y3 years | +367.6% | -7.9% | +508.0% |
| 5 y5 years | +270.1% | +162.5% | +161.6% |
ALDX Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.5% | +1.6% | -6.0% | +4.0% | -4.8% | at low |
| 5 y | 5-year | -0.5% | +367.6% | -13.8% | +139.0% | -4.8% | +508.0% |
| alltime | all time | -0.5% | -100.0% | -13.8% | +139.0% | -4.8% | -100.0% |
Aldeyra Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $63.00 K(+2.3%) | $251.70 K(-0.8%) |
| Jun 2024 | - | $61.60 K(+1.7%) | $253.70 K(-1.1%) |
| Mar 2024 | - | $60.60 K(-8.9%) | $256.40 K(-2.4%) |
| Dec 2023 | $262.80 K(+1.6%) | $66.50 K(+2.3%) | $262.80 K(-0.0%) |
| Sep 2023 | - | $65.00 K(+1.1%) | $262.90 K(-0.1%) |
| Jun 2023 | - | $64.30 K(-4.0%) | $263.20 K(+0.1%) |
| Mar 2023 | - | $67.00 K(+0.6%) | $262.90 K(+1.7%) |
| Dec 2022 | $258.70 K(-2.1%) | $66.60 K(+2.0%) | $258.60 K(+2.1%) |
| Sep 2022 | - | $65.30 K(+2.0%) | $253.30 K(-1.2%) |
| Jun 2022 | - | $64.00 K(+2.1%) | $256.40 K(-1.0%) |
| Mar 2022 | - | $62.70 K(+2.3%) | $259.10 K(-2.0%) |
| Dec 2021 | $264.20 K(+370.1%) | $61.30 K(-10.4%) | $264.30 K(+538.4%) |
| Sep 2021 | - | $68.40 K(+2.5%) | $41.40 K(-10.2%) |
| Jun 2021 | - | $66.70 K(-1.8%) | $46.10 K(-11.3%) |
| Mar 2021 | - | $67.90 K(-142.0%) | $52.00 K(-7.3%) |
| Dec 2020 | $56.20 K(-41.6%) | -$161.60 K(-321.1%) | $56.10 K(-76.8%) |
| Sep 2020 | - | $73.10 K(+0.7%) | $241.70 K(+25.5%) |
| Jun 2020 | - | $72.60 K(+0.8%) | $192.60 K(+33.8%) |
| Mar 2020 | - | $72.00 K(+200.0%) | $144.00 K(+49.7%) |
| Dec 2019 | $96.30 K(+35.6%) | $24.00 K(0.0%) | $96.20 K(+1.3%) |
| Sep 2019 | - | $24.00 K(0.0%) | $95.00 K(+5.7%) |
| Jun 2019 | - | $24.00 K(-0.8%) | $89.90 K(+7.3%) |
| Mar 2019 | - | $24.20 K(+6.1%) | $83.80 K(+18.0%) |
| Dec 2018 | $71.00 K | $22.80 K(+20.6%) | $71.00 K(+26.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $18.90 K(+5.6%) | $56.10 K(+18.9%) |
| Jun 2018 | - | $17.90 K(+57.0%) | $47.20 K(+19.2%) |
| Mar 2018 | - | $11.40 K(+44.3%) | $39.60 K(+4.5%) |
| Dec 2017 | $37.80 K(+5.6%) | $7900.00(-21.0%) | $37.90 K(-3.6%) |
| Sep 2017 | - | $10.00 K(-2.9%) | $39.30 K(+1.8%) |
| Jun 2017 | - | $10.30 K(+6.2%) | $38.60 K(+3.5%) |
| Mar 2017 | - | $9700.00(+4.3%) | $37.30 K(+4.5%) |
| Dec 2016 | $35.80 K(+90.4%) | $9300.00(0.0%) | $35.70 K(+3.5%) |
| Sep 2016 | - | $9300.00(+3.3%) | $34.50 K(+8.5%) |
| Jun 2016 | - | $9000.00(+11.1%) | $31.80 K(+24.7%) |
| Mar 2016 | - | $8100.00(0.0%) | $25.50 K(+36.4%) |
| Dec 2015 | $18.80 K(+1609.1%) | $8100.00(+22.7%) | $18.70 K(+65.5%) |
| Sep 2015 | - | $6600.00(+144.4%) | $11.30 K(+126.0%) |
| Jun 2015 | - | $2700.00(+107.7%) | $5000.00(+117.4%) |
| Mar 2015 | - | $1300.00(+85.7%) | $2300.00(+130.0%) |
| Dec 2014 | $1100.00(>+9900.0%) | $700.00(+133.3%) | $1000.00(+233.3%) |
| Sep 2014 | - | $300.00(>+9900.0%) | $300.00(>+9900.0%) |
| Jun 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2013 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00 | $0.00 |
| Dec 2012 | $3700.00(+131.3%) | - | - |
| Dec 2011 | $1600.00 | - | - |
FAQ
- What is Aldeyra Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics annual D&A year-on-year change?
- What is Aldeyra Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics quarterly D&A year-on-year change?
- What is Aldeyra Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics TTM D&A year-on-year change?
What is Aldeyra Therapeutics annual depreciation & amortization?
The current annual D&A of ALDX is $262.80 K
What is the all time high annual D&A for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high annual depreciation & amortization is $264.20 K
What is Aldeyra Therapeutics annual D&A year-on-year change?
Over the past year, ALDX annual depreciation & amortization has changed by +$4100.00 (+1.58%)
What is Aldeyra Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of ALDX is $63.00 K
What is the all time high quarterly D&A for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high quarterly depreciation & amortization is $73.10 K
What is Aldeyra Therapeutics quarterly D&A year-on-year change?
Over the past year, ALDX quarterly depreciation & amortization has changed by -$2000.00 (-3.08%)
What is Aldeyra Therapeutics TTM depreciation & amortization?
The current TTM D&A of ALDX is $251.70 K
What is the all time high TTM D&A for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high TTM depreciation & amortization is $264.30 K
What is Aldeyra Therapeutics TTM D&A year-on-year change?
Over the past year, ALDX TTM depreciation & amortization has changed by -$11.20 K (-4.26%)